Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Marcella Tschautscher, S. Vincent Rajkumar, Francis Buadi, Morie A. Gertz, Martha Lacy, Angela Dispenzieri, Suzanne R. Hayman, Yi Lisa Hwa, Amie L. Fonder, Miriam A. Hobbs, Steven R. Zeldenrust, John Anthony Lust, Nelson Leung, Prashant Kapoor, Taxiarchis Kourelis, Rahma M. Warsame, Ronald S. Go, Wilson I. Gonsalves, Robert A. Kyle, Shaji Kumar
Institution: Mayo Clinic
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890310852